CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway
Authors
Keywords
Ovarian carcinoma, Peritoneal dissemination, Mesothelial cells, CCL2, CCR2, TGF-β
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-21
DOI
10.1007/s10585-019-09993-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Ovarian Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
- (2018) Jennifer Pasquier et al. Molecular Cancer
- Prognostic factors in epithelial ovarian cancer: A population-based study
- (2018) Lin-Chau Chang et al. PLoS One
- Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer
- (2018) Jeremy Chien et al. Frontiers in Oncology
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways
- (2016) Jiao Liu et al. CANCER LETTERS
- MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial–mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells
- (2016) Shun Li et al. Cellular & Molecular Immunology
- Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs
- (2016) Soozana Puvanenthiran et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2013 and Treatment Annual Report for 2008
- (2016) Toshiaki Saito et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors
- (2016) Justyna Mikuła-Pietrasik et al. MEDICAL ONCOLOGY
- CCL2-CCR2 Signaling in Disease Pathogenesis
- (2015) Tracy O’Connor et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Chemokines in tumor progression and metastasis
- (2015) Purvaba J. Sarvaiya et al. Oncotarget
- Plasticity in Tumor-Promoting Inflammation: Impairment of Macrophage Recruitment Evokes a Compensatory Neutrophil Response
- (2015) Jessica C. Pahler et al. NEOPLASIA
- Chemokine Receptors in Epithelial Ovarian Cancer
- (2014) Goda Muralidhar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Chemokine (CCL2–CCR2) Signaling Axis Mediates Perineural Invasion
- (2014) Shizhi He et al. MOLECULAR CANCER RESEARCH
- Expression of the miR200 Family of microRNAs in Mesothelial Cells Suppresses the Dissemination of Ovarian Cancer Cells
- (2014) K. Sugiyama et al. MOLECULAR CANCER THERAPEUTICS
- CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro
- (2014) Igor Tsaur et al. WORLD JOURNAL OF UROLOGY
- CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration
- (2013) Tien-Huang Lin et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
- (2013) Y Yu et al. BRITISH JOURNAL OF CANCER
- The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
- (2012) A Popple et al. BRITISH JOURNAL OF CANCER
- TGF-β signalling and its role in cancer progression and metastasis
- (2012) Yvette Drabsch et al. CANCER AND METASTASIS REVIEWS
- Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
- (2012) Monika Julia Wolf et al. CANCER CELL
- CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
- (2012) A. Tsuyada et al. CANCER RESEARCH
- CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms
- (2012) Wei Bin Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) N. Colombo et al. ANNALS OF ONCOLOGY
- 7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: A novel compound capable of inducing cell death in epithelial ovarian cancer stem cells
- (2010) Jamie M. Green et al. CANCER BIOLOGY & THERAPY
- Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
- (2010) E. Giannoni et al. CANCER RESEARCH
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
- (2009) Patrick O. Brown et al. PLOS MEDICINE
- Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment
- (2008) Morgan O'Hayre et al. BIOCHEMICAL JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started